ENDOMETRIAL CANCER
Clinical trials for ENDOMETRIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CANCER trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New short radiation course shows promise for endometrial cancer patients
Disease control CompletedThis study tested a shorter course of pelvic radiation after hysterectomy in 25 women with advanced endometrial cancer. The goal was to see if the shorter treatment causes fewer side effects while still controlling the cancer as well as the standard 5-6 week radiation. Participan…
Matched conditions: ENDOMETRIAL CANCER
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
New pill may extend remission in advanced endometrial cancer
Disease control CompletedThis study tested whether taking the drug selinexor after chemotherapy can help keep advanced or recurrent endometrial cancer from growing back. About 263 women whose cancer had shrunk or disappeared after chemo were randomly assigned to receive selinexor or a placebo once a week…
Matched conditions: ENDOMETRIAL CANCER
Phase: PHASE3 • Sponsor: Karyopharm Therapeutics Inc • Aim: Disease control
Last updated May 16, 2026 23:38 UTC
-
New combo therapy shows promise in advanced skin and uterine cancers
Disease control CompletedThis study tested a new drug combination (MK-4280A) in 163 people with either a type of skin cancer (cutaneous squamous cell carcinoma) or endometrial cancer. The goal was to see if the treatment could shrink or eliminate tumors. Participants received either the new combination o…
Matched conditions: ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug combo shows promise in early cancer trial
Disease control CompletedThis early-phase study tested a new drug called TPST-1495, alone or with pembrolizumab, in 89 people with advanced solid tumors (like colorectal, lung, or head and neck cancer) that had stopped responding to standard treatments. The main goal was to find the safest dose and check…
Matched conditions: ENDOMETRIAL CANCER
Phase: PHASE1 • Sponsor: Tempest Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug cocktail shows promise for Tough-to-Treat uterine cancer
Disease control CompletedThis study tested a combination of three drugs (bevacizumab, atezolizumab, and rucaparib) in 30 people with endometrial cancer that had come back or continued to grow after prior treatment. The goal was to see if the drug mix could shrink tumors or slow the cancer. The trial is c…
Matched conditions: ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New triple therapy aims to beat drug-resistant cancers
Disease control CompletedThis study tested a combination of three drugs (afuresertib, sintilimab, and chemotherapy) in 22 adults with solid tumors like lung, cervical, or stomach cancer that had stopped responding to prior immunotherapy. The goal was to find the safest dose and see if the combo could shr…
Matched conditions: ENDOMETRIAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Laekna Limited • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New cancer drug shows promise in early safety trial
Disease control CompletedThis early-stage study tested a new drug called RP903 in 69 people with advanced solid tumors (like ovarian, breast, or cervical cancer) who had no other treatment options. The main goal was to check the drug's safety and find the right dose, not to cure the cancer. While some pa…
Matched conditions: ENDOMETRIAL CANCER
Phase: PHASE1 • Sponsor: Risen (Suzhou) Pharma Tech Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
Internal radiation blast shows promise for multiple cancers
Disease control CompletedThis study tested a high-dose internal radiation method called brachytherapy in 43 people with cervical, endometrial, esophageal, prostate, or biliary cancer. The goal was to see if the radiation implants could be placed accurately to deliver the right dose. Participants received…
Matched conditions: ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
New hope for chemo patients: triple therapy cuts nausea and vomiting
Symptom relief CompletedThis study looked at whether adding the drug aprepitant to the usual two anti-nausea medicines can better prevent nausea and vomiting caused by chemotherapy in people with gynecologic cancers like ovarian, cervical, and endometrial cancer. 143 patients took part. The goal was to …
Matched conditions: ENDOMETRIAL CANCER
Phase: PHASE3 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Symptom relief
Last updated May 16, 2026 23:49 UTC
-
Exercise boosts heart health in cancer survivors
Symptom relief CompletedThis study looked at whether a 12-week program of aerobic and strength exercises could improve heart health and fitness in women who finished treatment for endometrial cancer. 33 survivors participated. The goal was to see if exercise helps blood vessels work better and reduces h…
Matched conditions: ENDOMETRIAL CANCER
Phase: NA • Sponsor: Jess S. Gorzelitz • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
Brain training at home shows promise for Cancer-Related 'Chemo Brain'
Symptom relief CompletedThis study tested a home-based brain training program for 60 women who had finished chemotherapy for gynecologic cancers (like ovarian or uterine cancer) and were experiencing memory or thinking problems. Participants used a computer program called BrainHQ for 10 weeks. The goal …
Matched conditions: ENDOMETRIAL CANCER
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated May 12, 2026 13:41 UTC
-
Shorter radiation course shows promise for endometrial cancer patients
Symptom relief CompletedThis study looked at a shorter, more intense radiation schedule for people with endometrial cancer after surgery. The goal was to see if it is safe and does not cause too many side effects. Eight participants were followed for three months to check for bladder and bowel issues an…
Matched conditions: ENDOMETRIAL CANCER
Phase: NA • Sponsor: Teresa Meier • Aim: Symptom relief
Last updated May 07, 2026 18:41 UTC
-
Chatbot aims to boost genetic testing in cancer survivors
Knowledge-focused CompletedThis study tested a digital tool (a chatbot) to help cancer survivors learn about genetic testing for hereditary cancer risk. 50 adults who had certain cancers (like breast, ovarian, or prostate) took part. The goal was to see if the chatbot was easy to use and if it helped more …
Matched conditions: ENDOMETRIAL CANCER
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated May 16, 2026 23:50 UTC
-
Which lymph node removal level works best for endometrial cancer?
Knowledge-focused CompletedThis study looked at 150 women with intermediate- or high-risk endometrial cancer to compare two levels of lymph node removal during surgery: high versus low para-aortic lymphadenectomy. The goal was to see which approach gives better information about cancer spread and helps gui…
Matched conditions: ENDOMETRIAL CANCER
Phase: NA • Sponsor: Ahmed Aouf • Aim: Knowledge-focused
Last updated May 16, 2026 23:50 UTC
-
Blood mineral levels could hint at women's reproductive diseases
Knowledge-focused CompletedThis study measured 14 different trace elements (like iron, selenium, and lead) in the blood of women with endometriosis, ovarian cancer, or endometrial cancer, and compared them to healthy women. The goal was to see if certain minerals are higher or lower in these conditions. Ea…
Matched conditions: ENDOMETRIAL CANCER
Phase: NA • Sponsor: Cumhuriyet University • Aim: Knowledge-focused
Last updated May 16, 2026 23:49 UTC
-
Exercise before surgery may slow cancer growth
Knowledge-focused CompletedThis study looked at whether high-intensity interval training (HIIT) before standard surgery could have anti-cancer effects in women with endometrial cancer. Thirty women participated, and researchers measured changes in tumor growth markers in tissue samples taken before and aft…
Matched conditions: ENDOMETRIAL CANCER
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 16, 2026 23:49 UTC
-
Michigan study tests new ways to boost genetic testing in cancer patients
Knowledge-focused CompletedThis study looked at whether a special website or coaching phone calls could help more people with a personal or family history of certain cancers get genetic testing. Over 800 participants were randomly assigned to use a mobile website, receive two motivational coaching calls, o…
Matched conditions: ENDOMETRIAL CANCER
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Knowledge-focused
Last updated May 16, 2026 23:49 UTC
-
Can a nurse and a smartphone app improve life after gynecologic cancer?
Knowledge-focused CompletedThis study tested a new follow-up approach for people who finished treatment for gynecologic cancers like ovarian, endometrial, cervical, or vulvar cancer. Instead of seeing a doctor every time, patients met with a nurse at every other visit and used a smartphone app to learn sel…
Matched conditions: ENDOMETRIAL CANCER
Phase: NA • Sponsor: Sorlandet Hospital HF • Aim: Knowledge-focused
Last updated May 16, 2026 23:49 UTC
-
New clinic aims to help women thrive after cancer
Knowledge-focused CompletedThis study tested a special clinic for women who finished treatment for early-stage breast or gynecologic cancer. The clinic used online surveys to track symptoms and connect patients with nurses or dietitians when needed. The goal was to see if this approach is practical and hel…
Matched conditions: ENDOMETRIAL CANCER
Phase: NA • Sponsor: University College Cork • Aim: Knowledge-focused
Last updated May 16, 2026 23:38 UTC
-
Real-World data shows T-DXd may outperform standard care for HER2 cancers
Knowledge-focused CompletedThis study looked at how well the drug T-DXd works compared to usual treatments for people with several types of advanced cancers that have high levels of a protein called HER2. Researchers used existing data from earlier trials and real-world medical records to compare outcomes.…
Matched conditions: ENDOMETRIAL CANCER
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 16, 2026 23:38 UTC
-
Chemo's toll on daily life: study probes Long-Term effects in endometrial cancer patients
Knowledge-focused CompletedThis study looked at how chemotherapy affects the overall quality of life in women treated for stage II or III endometrial cancer. Researchers surveyed 51 women at least two years after their treatment ended, using standard questionnaires to measure physical, emotional, and socia…
Matched conditions: ENDOMETRIAL CANCER
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Knowledge-focused
Last updated May 16, 2026 23:38 UTC
-
New surgical approach may lower brain pressure during hysterectomy
Knowledge-focused CompletedThis study looked at 66 women having hysterectomy (removal of the uterus) to compare two surgical methods: traditional laparoscopic surgery and a newer vaginal approach called vNOTES. The goal was to see if vNOTES causes less pressure on the brain during the procedure. Researcher…
Matched conditions: ENDOMETRIAL CANCER
Phase: NA • Sponsor: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 12:07 UTC
-
Taiwan study maps HER2 in Hard-to-Treat gynecologic cancers
Knowledge-focused CompletedThis study reviewed medical records of 509 adults in Taiwan with advanced endometrial, ovarian, or cervical cancer. Researchers wanted to find out how many of these cancers have high levels of a protein called HER2 (IHC 3+). This information could help doctors identify patients w…
Matched conditions: ENDOMETRIAL CANCER
Sponsor: Daiichi Sankyo • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
New dye technique may help surgeons spot hidden cancer cells in real time
Knowledge-focused CompletedThis study tested a new method for injecting a green dye to help surgeons find lymph nodes during robotic surgery for early-stage endometrial cancer. The new method uses real-time imaging to guide the injection, aiming to find more lymph nodes on both sides of the pelvis. 80 pati…
Matched conditions: ENDOMETRIAL CANCER
Phase: NA • Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Chemo's hidden toll: taste loss and muscle wasting in gynecologic cancer patients
Knowledge-focused CompletedThis study followed 102 women with ovarian, fallopian tube, or endometrial cancer to see how standard chemotherapy (carboplatin and paclitaxel) changes their sense of taste, muscle mass, and nutrition. Researchers measured these effects before, during, and after six cycles of tre…
Matched conditions: ENDOMETRIAL CANCER
Sponsor: Ankara Etlik City Hospital • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC